Evidence map›Paper›PMID 37739465›Full record

ArticleBMJ open2023

Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol.

Fatima Kassymbekova, Indira Zhetpisbayeva, Evgeniya Tcoy, Rassul Dyussenov, Kairat Davletov, Alexander Rommel, Natalya Glushkova

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Fatima KassymbekovaDepartment of Public Health and Social Sciences, Kazakhstan Medical University "KSPH", Almaty, Kazakhstan f.kassymbekova@gmail.com.ORCID 0000-0001-6440-5590
Indira ZhetpisbayevaDepartment of Public Health and Social Sciences, Kazakhstan Medical University "KSPH", Almaty, Kazakhstan.
Evgeniya TcoyDepartment of Obstetrics and Gynaecology, Kazakh-Russian Medical University, Almaty, Kazakhstan.
Rassul DyussenovDepartment of Public Health and Social Sciences, Kazakhstan Medical University "KSPH", Almaty, Kazakhstan.
Kairat DavletovHealth Research Center, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Alexander RommelEpidemiology and Health Monotoring, Robert Koch Institute, Berlin, Germany.
Natalya GlushkovaDepartment of Epidemiology, Biostatistics and Evidence Based Medicine, Al-Farabi Kazakh National University, Almaty, Kazakhstan.ORCID 0000-0003-1400-8436
Kazakhstan Medical University · KZAl-Farabi Kazakh National University · KZKazakh National Medical University · KZRobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHuman papillomavirus (HPV) is a prevalent sexually transmitted infection linked to certain types of malignant neoplasms, notably cervical cancer (CC). In Kazakhstan, a high prevalence of high oncogenic HPV types (HR-HPV) has been observed, and CC ranks as the second most common malignancy among women with a crude incidence rate of 18.3 cases per 100 000 women. The HPV vaccine, developed as the primary prevention measure against HPV infection, including the most prevalent HR-HPV, received approval from the WHO in 2009. In 2014, Kazakhstan initiated HPV vaccination as a pilot project in four sub-national regions; however, it was later in 2017 discontinued due to widespread parental refusal influenced by negative media reports. This study aims to examine knowledge, attitudes, information sources, barriers to HPV vaccination and factors associated with HPV vaccination hesitancy among different target groups in Kazakhstan prior to the HPV vaccine re-launch announced by the Ministry of Health. METHODS AND ANALYSIS: This mixed-method-designed research comprises quantitative and qualitative components. Data on HPV awareness, attitudes towards HPV vaccination and sources of information will be collected through an online survey administered by parents and legal guardians, health professionals, and schoolteachers in the Republic of Kazakhstan between January 2023 and January 2024. Additionally, qualitative data on Kazakhstani parental beliefs and attitudes toward HPV vaccination will be collected through online focus group discussions. ETHICS AND DISSEMINATION OF

resultsThe study has been approved by the local ethics committee at the Kazakhstan Medical University "Higher School of Public Health" (KMU "KSPH") (No. 138 of 31.05.2021). The results will be reported in publications, at conferences among researchers and healthcare and school education professionals in Kazakhstan, and internationally.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsVaccinesFemaleHealth Knowledge, Attitudes, PracticeHuman Papillomavirus VirusesHumansInformation SourcesKazakhstanPilot ProjectsVaccinesAdolescentGynaecological oncologyHead & neck tumoursPrimary Health CarePrimary PreventionPUBLIC HEALTH

Identifiers

PMID37739465
PMCPMC10533667
OpenAlexW4386969463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.